FDA Clears Expanded Bone Graft Options for Kids

Subscribe today to listen to this content Get Access

For years, orthopedic surgeons treating pediatric fractures and benign bone lesions have faced a familiar challenge: finding a grafting material that offers surgical flexibility without lingering long after it’s needed.

That gap may soon narrow. The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for pediatric use of three magnesium-based bone graft substitutes from Bone Solutions, Inc.